Urinary Microbiota Composition in Treatment-Naïve Bladder Cancer: A Case–Control Study with Tumor Invasiveness Stratification

<i>Background and Objectives</i>: Emerging evidence suggests that the genitourinary microbiota may influence the development and progression of urological malignancies, including bladder cancer. This study aimed to characterize the urinary microbiota at diagnosis in patients with bladder cancer and compare findings with healthy controls. <i>Materials and Methods:</i> Urine samples were collected from 30 patients with treatment-naïve bladder cancer and 20 age- and sex-matched healthy individuals. Microbiota composition was analyzed using 16S rRNA sequencing, and subgroup comparisons were made between muscle-invasive bladder cancer (MIBC) and non-muscle-invasive bladder cancer (NMIBC). Differentially abundant taxa were identified using linear discriminant analysis effect size (LEfSe) with an LDA threshold > 2 and <i>p</i> < 0.05. <i>Results:</i> No significant differences were observed in alpha or beta diversity between patients and controls or between MIBC and NMIBC. At the phylum level, <i>Firmicutes</i> was dominant in both groups but relatively more abundant in bladder cancer cases. <i>Enterococcus</i> was the most abundant genus in the cancer group (35.0%) and especially in MIBC (58.0%), while <i>Lactobacillus</i> was more prevalent in healthy controls (19.8% vs. 9.5%). At the species level, <i>Veillonella dispar</i> was notably enriched in MIBC cases (70.9%) compared to NMIBC (3.9%). LEfSe analysis revealed significant enrichment of <i>Ralstonia</i>, <i>Microbacterium</i>, and <i>Facklamia</i> in patients with bladder cancer, while <i>Parvimonas</i>, <i>Sneathia</i>, <i>Gemella</i>, and <i>Acinetobacter guillouiae</i> were more abundant in controls. <i>Conclusions:</i> These findings highlight preliminary microbiota differences associated with bladder cancer and tumor invasiveness; however, the results are exploratory and larger studies are required to evaluate their diagnostic or clinical relevance.

Authors

Institutions

Publication Details

Journal
Medicina
Published
2025-12-18
DOI
https://doi.org/10.3390/medicina61122240
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Urinary Microbiota Composition in Treatment-Naïve Bladder Cancer: A Case–Control Study with Tumor Invasiveness Stratification

Ata Özen, Ener Çağrı Dinleyici, Ahmet Kayer
Medicina
Gut microbiota and health
article

Urinary Microbiota Composition in Treatment-Naïve Bladder Cancer: A Case–Control Study with Tumor Invasiveness Stratification

Ata Özen, Ener Çağrı Dinleyici, Ahmet Kayer
article en

Abstract

<i>Background and Objectives</i>: Emerging evidence suggests that the genitourinary microbiota may influence the development and progression of urological malignancies, including bladder cancer. This study aimed to characterize the urinary microbiota at diagnosis in patients with bladder cancer and compare findings with healthy controls. <i>Materials and Methods:</i> Urine samples were collected from 30 patients with treatment-naïve bladder cancer and 20 age- and sex-matched healthy individuals. Microbiota composition was analyzed using 16S rRNA sequencing, and subgroup comparisons were made between muscle-invasive bladder cancer (MIBC) and non-muscle-invasive bladder cancer (NMIBC). Differentially abundant taxa were identified using linear discriminant analysis effect size (LEfSe) with an LDA threshold > 2 and <i>p</i> < 0.05. <i>Results:</i> No significant differences were observed in alpha or beta diversity between patients and controls or between MIBC and NMIBC. At the phylum level, <i>Firmicutes</i> was dominant in both groups but relatively more abundant in bladder cancer cases. <i>Enterococcus</i> was the most abundant genus in the cancer group (35.0%) and especially in MIBC (58.0%), while <i>Lactobacillus</i> was more prevalent in healthy controls (19.8% vs. 9.5%). At the species level, <i>Veillonella dispar</i> was notably enriched in MIBC cases (70.9%) compared to NMIBC (3.9%). LEfSe analysis revealed significant enrichment of <i>Ralstonia</i>, <i>Microbacterium</i>, and <i>Facklamia</i> in patients with bladder cancer, while <i>Parvimonas</i>, <i>Sneathia</i>, <i>Gemella</i>, and <i>Acinetobacter guillouiae</i> were more abundant in controls. <i>Conclusions:</i> These findings highlight preliminary microbiota differences associated with bladder cancer and tumor invasiveness; however, the results are exploratory and larger studies are required to evaluate their diagnostic or clinical relevance.

MedicinaVol. 61(12)
Eskişehir Osmangazi University (TR)
Openalex Percentile: Top 63%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.